Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
2004 1
2005 3
2006 4
2008 5
2009 2
2010 9
2011 7
2012 9
2013 6
2014 1
2015 4
2016 1
2017 1
2018 4
2019 3
2020 3
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

56 results
Results by year
Filters applied: . Clear all
Page 1
A novel dopamine D3R agonist SK609 with norepinephrine transporter inhibition promotes improvement in cognitive task performance in rodent and non-human primate models of Parkinson's disease.
Schneider JS, Marshall CA, Keibel L, Snyder NW, Hill MP, Brotchie JM, Johnston TH, Waterhouse BD, Kortagere S. Schneider JS, et al. Among authors: johnston th. Exp Neurol. 2021 Jan;335:113514. doi: 10.1016/j.expneurol.2020.113514. Epub 2020 Oct 22. Exp Neurol. 2021. PMID: 33141071 Free PMC article.
Drugs in development for Parkinson's disease.
Johnston TH, Brotchie JM. Johnston TH, et al. Curr Opin Investig Drugs. 2004 Jul;5(7):720-6. Curr Opin Investig Drugs. 2004. PMID: 15298067 Review.
56 results